glp-1 eye GLP-1s and Health: What You Need to Know Study Disputes Link Between GLP-1
Description
August 2024: A data analysis examining how semaglutide drugs in the GLP-1 agonist family might cause blood clots is being re-examined
10.2515/therapie/2012076 12 CaoC.YangS.ZhouZ
GLP-1 RAs get explored for curing NASH, CVDs Apart from GLP-1 RA and dual agonists, drugmakers like Eli Lilly and Hanmi are also working on triple agonists
FDA Approves Once-Weekly Wegovy Injection for the Treatment of Obesity in Teens Aged 12 Years and Older
This is a full, complete stack designed to hit every mark for lasting change
However, a major shift occurred in November 2025 when the Trump administration negotiated MFN pricing deals with Novo Nordisk and Eli Lilly, reducing Medicare/Medicaid prices for Ozempic, Wegovy, Zepbound, and Mounjaro to approximately $245/month , with Medicare beneficiary co-pays of $50/month ( [17] ) ( [22] )
